Evan Levine is President at ADVENTRX PHARMACEUTICALS INC (ANX). They have made 6 open-market trades across 3 companies since 2004, most recently 2018-11-30.
CIK 0001199838
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $8.0M since 2004, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PBYA | BUY | 2016-11-08 | 2017-02-21 | $0.80 | $7.9M | N/A | N/A | N/A |
| ANX | BUY | 2008-02-08 | 2008-04-15 | $0.51 | $3K | N/A | N/A | N/A |
| ANX | BUY | 2007-12-14 | 2007-12-17 | $0.45 | $27K | N/A | N/A | N/A |
| QTXB | SELL | 2007-02-06 | 2007-02-09 | $0.70 | $559K | N/A | N/A | N/A |
| ANX | SELL | 2005-03-22 | 2008-04-15 | $2.28 | $34K | N/A | N/A | N/A |
| ANX | BUY | 2004-10-04 | 2008-04-15 | $1.61 | $39K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.